Search

Author/Creator Muratori, Luca

1. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. Issue 9 (September 2022)

Authors:
Giannini, Edoardo G.; Pieri, Giulia; Labanca, Sara; Plaz Torres, Maria Corina; Gasbarrini, Antonio; Biasini, Elisabetta; Campani, Claudia; Cazzagon, Nora; Foschi, Francesco Giuseppe; Mega, Andrea; Masotto, Alberto; Raimondo, Giovanni; Rapaccini, Gian Ludovico; Sacco, Rodolfo; Caturelli, Eugenio; ...
Journal:
Digestive and liver disease
Issue:
Volume 54:Issue 9(2022)
Page Start:
1215
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (November 2021)

Authors:
Cucchetti, Alessandro; Gramenzi, Annagiulia; Johnson, Philip; Giannini, Edoardo G.; Tovoli, Francesco; Rapaccini, Gian Ludovico; Marra, Fabio; Cabibbo, Giuseppe; Caturelli, Eugenio; Gasbarrini, Antonio; Svegliati-Baroni, Gianluca; Sacco, Rodolfo; Zoli, Marco; Morisco, Filomena; Di Marco, Maria; M...
Journal:
European journal of cancer
Issue:
Volume 158(2021)
Page Start:
133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors. Issue 11 (November 2022)

Authors:
Stefanini, Benedetta; Bucci, Laura; Santi, Valentina; Reggidori, Nicola; Rampoldi, Davide; Lani, Lorenzo; Granito, Alessandro; Sangiovanni, Angelo; Cabibbo, Giuseppe; Farinati, Fabio; Campani, Claudia; Foschi, Francesco Giuseppe; Svegliati-Baroni, Gianluca; Raimondo, Giovanni; Gasbarrini, Antonio...
Journal:
Digestive and liver disease
Issue:
Volume 54:Issue 11(2022)
Page Start:
1563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Issue 7 (July 2022)

Authors:
Pelizzaro, Filippo; Peserico, Giulia; D'Elia, Marco; Cazzagon, Nora; Russo, Francesco Paolo; Vitale, Alessandro; Giannini, Edoardo G.; Piccinnu, Manuela; Rapaccini, Gian Ludovico; Di Marco, Maria; Caturelli, Eugenio; Zoli, Marco; Sacco, Rodolfo; Cabibbo, Giuseppe; Marra, Fabio; Mega, Andrea; Mori...
Journal:
Digestive and liver disease
Issue:
Volume 54:Issue 7(2022)
Page Start:
927
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗